PDE3A / TRP channels
Name: cGMP-inhibited 3',5'-cyclic phosphodiesterase A
(PDE3A)
Official Symbol: PDE3A
provided by HGNC
Function:
Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (By similarity).
Source: Reorganizing the protein space at the Universal Protein Resource (UniProt)
Nucleic Acids Res. 40: D71-D75 (2012).
Species | External DB | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Entrez Gene | UniprotKB | DIP | IntAct | MINT | BioGRID | STRING | IUPHAR-DB | KEGG | OMIM | |
Human
|
5139 | Q14432 | DIP-42197N | MINT-3295914 | 111165 | Q14432 | hsa:5139 | 123805 | ||
Mouse
|
54611 | Q9Z0X4 | DIP-44006N | MINT-4049569 | 207686 | Q9Z0X4 | mmu:54611 | |||
Rat
|
50678 | Q62865 | MINT-4598018 | 248419 | Q62865 | rno:50678 |
Biological Process:
- GO:0007596 : blood coagulation
- GO:0006198 : cAMP catabolic process
- GO:0019933 : cAMP-mediated signaling
- GO:0071321 : cellular response to cGMP
- GO:0071560 : cellular response to transforming growth factor beta stimulus
- GO:0019934 : cGMP-mediated signaling
- GO:0006629 : lipid metabolic process
- GO:0043066 : negative regulation of apoptotic process
- GO:0043116 : negative regulation of vascular permeability
- GO:0001556 : oocyte maturation
- GO:0060282 : positive regulation of oocyte development
- GO:0043117 : positive regulation of vascular permeability
- GO:0040020 : regulation of meiosis
- GO:0051591 : response to cAMP
- GO:0042493 : response to drug
Source: The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat. Genet.. May 2000;25(1):25-9.
World Wide Web URL: http://www.geneontology.org/
World Wide Web URL: http://www.geneontology.org/
Disease:
No information in OMIM
Source: Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine,
Johns Hopkins University (Baltimore, MD), May, 2012.
World Wide Web URL: http://omim.org/
World Wide Web URL: http://omim.org/
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Screening | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Experimental screening | Non-experimental screening | Reference | ||||||||
TRP channel construct | Interactor source | |||||||||
TRP channel | Interactor | Method | Species | Region | Species | Organ/tissue | Sample type | |||
TRPC3 | PDE3A | Inference | Prediction | 21799177 | ||||||
TRPC6 | PDE3A | Inference | Prediction | 21799177 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Validation: In vivo validation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Assay with endogenous proteins | Assay with overexpressed proteins | Reference | ||||||||
Cell or tissue | Cell or tissue | TRP channel construct | Interactor construct | |||||||
TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
TRPC3 | PDE3A | Co-immunoprecipitation | HEK293 | Not specified | Full-length | Not used | 21799177 | |||
TRPC6 | PDE3A | Co-immunoprecipitation | HEK293 | Mouse | Full-length | Not used | 21799177 | |||
TRPC6 | PDE3A | Co-immunoprecipitation | Rat aortic smooth muscle cell | 21799177 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)